Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.44 |
| ▸ | LTA4H | P09960 | 2/20 | 0.37 |
| ▸ | CETP | P11597 | 5/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | CPA1 | P15085 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3725757 | 1.00 | MME (0.44) | MMELTA4HCETPSMN1; SMN2RAB9A | |
| SCHEMBL14742983 | 0.98 | MME (0.45) | MMELTA4HCETPSMN1; SMN2RAB9A | |
| SCHEMBL5857636 | 0.84 | MME (0.42) | MMELTA4HSMN1; SMN2RAB9A | |
| SCHEMBL25901525 | 0.78 | MME (0.33) | MMESMN1; SMN2RAB9AACECPA1 | |
| SCHEMBL17181685 | 0.77 | MME (0.42) | MMELTA4HSMN1; SMN2RAB9A | |
| SCHEMBL997755 | 0.77 | MME (0.42) | MMELTA4HSMN1; SMN2RAB9A | |
| SCHEMBL19347273 | 0.76 | CETP (0.32) | CETP | |
| SCHEMBL13070545 | 0.75 | — | — | |
| SCHEMBL158231 | 0.75 | MME (0.43) | MMELTA4HCETPSMN1; SMN2RAB9A | |
| SCHEMBL6037209 | 0.75 | MME (0.43) | MMELTA4HCETPSMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188150-A1 | PEPTIDES FOR THE TREATMENT OF FIBROSIS | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED (IL) | 2025-06-12 | — | — | US | disclosed |
| US-20240398906-A1 | PROPEPTIDE OF LYSYL OXIDASE FOR TREATMENT OF CANCER | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-12-05 | — | — | US | disclosed |
| US-20240182532-A1 | MICROPEPTIDES AND USES THEREOF | FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) | 2024-06-06 | — | — | US | disclosed |
| US-11858972-B2 | Micropeptides and uses thereof | FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) | 2024-01-02 | — | — | US | disclosed |
| US-20220251153-A1 | PEPTIDES FOR THE TREATMENT OF RENAL DISORDERS | UGH PHARMA, INC. (PA) | 2022-08-11 | — | — | US | disclosed |
| US-20220120732-A1 | TREATMENT OF DISEASES WITH MULTIMERIC PEPTIDES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-04-21 | — | — | US | disclosed |
| US-20220049236-A1 | COMPOSITIONS COMPRISING THE PROPEPTIDE OF LYSYL OXIDASE AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-02-17 | — | — | US | disclosed |
| US-20210162025-A1 | VARIANTS OF TACE PRO-DOMAIN AS TNF-A INHIBITOR AND THEIR MEDICAL USE | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-06-03 | — | — | US | disclosed |
| US-10933122-B2 | Variants of TACE pro-domain as TNF-A inhibitor and their medical use | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-03-02 | — | — | US | disclosed |
| US-10906937-B2 | Peptides and compositions comprising same and uses thereof in the treatment of diseases | ARIEL-UNIVERSITY RESEARCH AND DEVELOPMENT COMPANY LTD. (IL) | 2021-02-02 | — | — | US | disclosed |
| US-20100298226-A1 | POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME AND USE THEREOF IN THE TREATMENT OF MEDICAL CONDITIONS ASSOCIATED WITH ISCHEMIA | VASCULAR BIOGENICS LTD. (IL) | 2010-11-25 | — | — | US | disclosed |
| US-20100279943-A1 | CYTOPLASMIC MALATE DEHYDROGENASE (MDH1) TARGETED TREATMENT FOR NEURODEGENERATIVE DISEASES | RAMAT AT TEL AVIV UNIVERSITY LTD. (IL) | 2010-11-04 | — | — | US | disclosed |
| CN-101820897-A | Cytoplasmic malate dehydrogenase (MDH1) targeted treatment for neurodegenerative diseases | UNIV RAMOT | 2010-09-01 | — | — | CN | disclosed |
| US-20100203609-A1 | PHOTOCATALYTIC HYDROGEN PRODUCTION AND POLYPEPTIDES CAPABLE OF SAME | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2010-08-12 | — | — | US | disclosed |
| US-20100104607-A1 | ANTI-BACTERIAL PEPTIDES AND METHODS OF TREATING DISEASES USING SAME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2010-04-29 | — | — | US | disclosed |
| US-20100093600-A1 | REGULATION OF NEUROTRANSMITTERS SEQUESTRATION AND RELEASE THROUGH MANIPULATION OF THE VESICULAR FUNCTIONS | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2010-04-15 | — | — | US | disclosed |
| US-20090305970-A1 | Toxin-Like Polypeptides, Polynucleotides Encoding Same and Uses Thereof | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2009-12-10 | — | — | US | disclosed |
| US-20090242879-A1 | Optoelectronic device and method of fabricating the same | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-10-01 | — | — | US | disclosed |
| US-7524929-B2 | polypeptides comprising an amino acid sequence of a photocatalytic unit of a photosynthetic microorganism, capable of maintaining photocatalytic activity when attached to solid surfaces of electrooptic devices | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-04-28 | — | — | US | disclosed |
| US-20080305471-A1 | polypeptides comprising an amino acid sequence of a photocatalytic unit of a photosynthetic microorganism, capable of maintaining photocatalytic activity when attached to solid surfaces of electrooptic devices | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2008-12-11 | — | — | US | disclosed |